Treatment of the elderly patient with small-cell lung cancer

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The population of the United States is gradually aging. Within a generation, over 20 percent of the population will be >65 years of age. Since cancer is a disease of older persons, the incidence of malignancies of all types is expected to increase during the coming decades. In general, since older patients appear to tolerate chemotherapy less well than their younger counterparts, strategies that lessen toxicity and yet maintain efficacy are desperately needed. Recently, the use of single-agent oral etoposide has been shown to be an effective palliative therapy for older patients with small- cell lung cancer. Future studies will need to focus on the unique requirements of older patients in order to improve therapy in these individuals.

Original languageEnglish (US)
JournalChest
Volume103
Issue number1 SUPPL.
StatePublished - 1992

Fingerprint

Small Cell Lung Carcinoma
Etoposide
Palliative Care
Population
Neoplasms
Therapeutics
Drug Therapy
Incidence

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Treatment of the elderly patient with small-cell lung cancer. / Johnson, D. H.

In: Chest, Vol. 103, No. 1 SUPPL., 1992.

Research output: Contribution to journalArticle

@article{7a01daccf3d94856bdc22ca5ebb43156,
title = "Treatment of the elderly patient with small-cell lung cancer",
abstract = "The population of the United States is gradually aging. Within a generation, over 20 percent of the population will be >65 years of age. Since cancer is a disease of older persons, the incidence of malignancies of all types is expected to increase during the coming decades. In general, since older patients appear to tolerate chemotherapy less well than their younger counterparts, strategies that lessen toxicity and yet maintain efficacy are desperately needed. Recently, the use of single-agent oral etoposide has been shown to be an effective palliative therapy for older patients with small- cell lung cancer. Future studies will need to focus on the unique requirements of older patients in order to improve therapy in these individuals.",
author = "Johnson, {D. H.}",
year = "1992",
language = "English (US)",
volume = "103",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Treatment of the elderly patient with small-cell lung cancer

AU - Johnson, D. H.

PY - 1992

Y1 - 1992

N2 - The population of the United States is gradually aging. Within a generation, over 20 percent of the population will be >65 years of age. Since cancer is a disease of older persons, the incidence of malignancies of all types is expected to increase during the coming decades. In general, since older patients appear to tolerate chemotherapy less well than their younger counterparts, strategies that lessen toxicity and yet maintain efficacy are desperately needed. Recently, the use of single-agent oral etoposide has been shown to be an effective palliative therapy for older patients with small- cell lung cancer. Future studies will need to focus on the unique requirements of older patients in order to improve therapy in these individuals.

AB - The population of the United States is gradually aging. Within a generation, over 20 percent of the population will be >65 years of age. Since cancer is a disease of older persons, the incidence of malignancies of all types is expected to increase during the coming decades. In general, since older patients appear to tolerate chemotherapy less well than their younger counterparts, strategies that lessen toxicity and yet maintain efficacy are desperately needed. Recently, the use of single-agent oral etoposide has been shown to be an effective palliative therapy for older patients with small- cell lung cancer. Future studies will need to focus on the unique requirements of older patients in order to improve therapy in these individuals.

UR - http://www.scopus.com/inward/record.url?scp=0027056434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027056434&partnerID=8YFLogxK

M3 - Article

VL - 103

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1 SUPPL.

ER -